English Version Schlieren, Switzerland, Munich, Germany, and Vienna, Austria, December 16, 2022 Clemedi AG concludes a license agreement for detecting latent tuberculosis with the Max Planck Society (MPG) and the Medical University of Vienna Clemedi aims to extend its tuberculosis product line to cover latent tuberculosis. This requires the ability to extract M. tuberculosis DNA…
read more